Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues

Histopathology

Volumn 40, Issue 5, 2002, Pages 472-479

  Kitagawa, Y ^a   Iwai, Masaki ^a   Muramatsu, A ^a   Tanaka, S ^a   Mori, T ^a   Harada, Y ^a   Okanoue, T ^a   Kashima, K ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Billary ducts; CA19 9; CEA; Chronic liver disease; DU PAN 2; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLINE; PROTEIN; PROTEIN CA19 9; PROTEIN DU PAN 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BILE DUCT; BLOOD ANALYSIS; CANCER CLASSIFICATION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTRAHEPATIC BILE DUCT; LAPAROSCOPY; LIVER; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER MEMBRANE; LIVER SURGERY; MIXED TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REGENERATION;

ANTIGENS, NEOPLASM; BILE DUCTS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MICROSCOPY, ELECTRON; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0036093564     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01374.x     Document Type: Article

References (42)

1. Specific carcinoembryonic antigens of the human digestive system
2. Use of antibody panels in the analysis of metastatic carcinomas of unknown primary
3. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigens) in serum and ascites of patients with adenocarcinoma
4. Radioimmunoassay for a monoclonal antibody-defined tumor marker CA19-9
5. Colorectal carcinoma antigens detected by hybridoma antibodies
6. Antigen of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies
7. The effect of benign and malignant liver disease on the tumor markers CA19-9 and CEA
8. Gastrointestinal cancer-associated antigen in immunoperoxidase assay
9. Monoclonal antibodies against human pancreatic adenocarcinoma: Distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinoma
10. Evaluation of the behavior of carcinoembryonic antigens in cirrhotic patients
11. Detection of an oncofetal antigen (DU-PAN-2) in sera of patients with non-malignant hepatobiliary diseases and hepatomas
12. Extrahepatic cholestasis determines a reversible increase of glycoprotein tumor markers in benign and malignant disease
13. Serum levels of carbohydrate antigen determinant (CA19-9) in obstructive jaundice
14. AFP in the diagnosis of human hepatomas
15. Serum alpha-fetoprotein in non-neoplastic liver diseases
16. 4-induced liver
17. Cellular analysis of α-fetoprotein gene activation during carbon tetrachloride and D-galactosamine-induced acute liver injury in rats
18. Electron microscopy of human liver disease
19. The development of proliferating ductular structures in liver disease - An immunohistochemical study
20. Kinetic analysis of malignant fibrous histiocytoma cells treated with anticancer agents in vivo
21. Hepatocyte regeneration in acute fulminant and non-fulminant hepatitis: A study of proliferating cell nuclear antigen expression
22. Classification of chronic hepatitis: Diagnosis, grading and staging
23. Combined liver cell and bile duct carcinoma
24. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled (PAP) procedure
25. Amplication of immunostaining intensity by the peroxidase-antiperoxidase, avidin-biotin-peroxidase complex or catalyzed signal amplification method gives erroneous antigen content in sections
26. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cell of rat liver
27. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells. Role for endogenous IFN-beta
28. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
29. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthyl-isothiocyanate (ANIT) administration
30. Cell adhesion of non-specific cross reacting (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: Homophilic and heterophilic adhesion
31. Specificity of intercellular adhesion mediated by various members of the immunoglobulin supergene family
32. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen
33. Histopathologic findings in chronic hepatitis C
34. Analysis of histological manifestations of chronic hepatitis C virus infection with respect to virus genotype
35. Proliferating cell nuclear antigen (PCNA) immunolocalisation in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neplasms
36. Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure
37. Immunohisto-chemical study of hepatic tumors - KMO1 stains compared with AFP, CEA, CA19-9 and Ras P21
38. Immunohistochemistry in differential diagnosis of liver carcinomas
39. Liver cell dysplasia and hepatocellular carcinoma and immunohistochemical study
40. Utility of polyclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates
41. Immunologic approaches to diagnosis of malignancies
42. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma